SLC2A3 and non-small cell lung carcinoma: As among all patients with NSCLC, GLUT1 expression was correlated with high FDG-PET SUVmax (6.8 ± 3.6 vs. 3.3 ± 2.5, p < 0.001), but GLUT3 expression showed no correlation with any other markers.